Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for Nonalcoholic fatty liver disease

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Effectiveness and Safety of Elafibranor for Patients with Nonalcoholic Fatty Liver Disease

    Jacksonville, FL

  2. A Study to Evaluate the Effectiveness and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis

    Scottsdale/Phoenix, AZ

  3. Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 2

    Scottsdale/Phoenix, AZ

  4. The Olmsted NAFLD Epidemiology Study (TONES)

    Rochester, MN

  5. Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram

    Rochester, MN

  6. A 5-year Observational Study of Patients With Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)

    Rochester, MN


Mayo Clinic Footer